I really enjoyed this topic because I was actually thinking about this question while going through this week’s module. I believe the decision ultimately depends on the resources available and how much time you have to complete the research. Each option has its own advantages, so I think the circumstances of the project would determine which one makes the most sense.

For example, if I were given a grant that was large enough to cover the cost of a contract lab, I would strongly consider that option, especially if they already had the equipment and experience needed for the research. On the other hand, if the project had a very extended deadline, I think an academic lab could be a good choice. The fact that academic labs may move at a different pace would not be as much of an issue if I had plenty of time to complete the research.

Personally, I think I would choose an in-house lab if I had a limited budget and a short timeline. While it may require more work and resources to manage internally, having more direct control over the research could make it easier to stay on schedule. Overall, I think the biggest factors I would consider are the budget, timeline, available equipment, and how much control I need over the research process.

To manage a preclinical research project, I would need to take into consideration the complexity of the study, resources available, timelines imposed, and budget limitations. An in-house lab would be favorable in projects where the testing process has to be controlled frequently or where there is strict timeline restrictions. However, it may be wiser to opt for an academic or contract lab should there be a need for specialized equipment or expertise. The greatest issue would be striking the balance between the amount of control one would have, the costs involved, expertise required, and the time available. Finally, when it comes to medical devices, one must also take into consideration the regulatory constraints, as well as whether the chosen lab has the relevant experience and can produce dependable test results with appropriate documentation.

Coming from an industry perspective, an academic lab would never be chosen due to the lead time and communication. Many large pharmaceutical companies have sites with vivariums or specialized labs to conduct pre-clinical research. My company typically has someone I can reach out to who is able to conduct research we don't have equipment for in our lab (i.e. an animal study). If the company doesn't have the resources in house, they will typically go to a third party contract lab rather than an academic lab. Although the contract lab costs more, industry project teams want to get to the finish line as fast as possible and the uncertainty in timing for academic labs is not something they can sacrifice and risk having someone else get there first. 

Coming from manufacturing, I believe in addition to cost, equipment and timeline, I might consider how much control I want to have over the research process. Being in a highly regulated industry has helped me to understand that obtaining a result may not be all. The way in which the work was done, the way it was documented, communicated and how the unforeseen problems were resolved may also be very important.

Thus, I would prefer in-house laboratories in case of their availability. Having personnel who is going to conduct the research within the organization can help in case some unforeseen event takes place. In addition, it may be much easier to communicate in such situations and make decisions immediately if necessary. However, it would be unreasonable to keep all research processes in-house just for the sake of having additional control.

I think for me the decision would really come down to which option creates the least risk for that specific project rather than having one option that is always better. Would you still choose an outside lab if it had much better expertise, even if it meant giving up some control over the timeline and day-to-day work?

@ahmed-elmonier I wouldn't use an outside lab for industry for the reason you mentioned, the reduced control and monitoring over the lab. For projects to maintain consistent deadlines, adding a non-affiliated entity to the project has increased potential for miscommunication and delays, as the researchers may conduct experiments to a different standard than what is required by your company. As a solution, I would say that hiring a specialist in academia as a consultant can get you the best of both worlds. You get the guidance of an academic professional as well as the desired control of the lab you mentioned. As long as you have the resources on hand for the lab (or have long-term need for the laboratory tools you purchase), I believe it's more preferable to use in-house labs with academic consultants.

Personally, it really depends on the project but an essential factor that should be taken into account for a project is the sensitivity or confidentiality of the brand new instruments or technology. In-house testing would be most preferred because the company would keep more of the technical knowledge and troubleshooting and hold the confidential information within the team. The knowledge can become important afterward when the product shifts to the design verification or manufacturing or if more additional testing is required. If the study were less proprietary, then I would lean towards utilizing a lab outside that has showcased a history of proven methodology and has showcased an experience with the research. The decision should take into account the test result as well as the knowledge gained during the study. From your perspective, how much intellectual property and long-term technical knowledge retention influence the option of outsourcing preclinical research?